Clinical Trial: Continuous Femoral Nerve Block Following Total Knee Replacement

This study is currently recruiting patients.
Verified by National Institute of General Medical Sciences (NIGMS) August 2005

Sponsors and Collaborators: National Institute of General Medical Sciences (NIGMS)
Foundation for Anesthesia Education and Research
Arrow International
Stryker Instruments
General Clinical Research Center Grant RR00082
Department of Anesthesiology, University of Florida
Information provided by: National Institute of General Medical Sciences (NIGMS)
ClinicalTrials.gov Identifier: NCT00135889

Purpose

To determine if putting local anesthetic—or numbing medication—through a tiny tube next to the nerves that go to your knee will improve pain control during physical therapy, and ultimately improve the results of surgery. It will also determine if patients having a knee replacement may receive the same or better pain control at home compared with staying in the hospital, and if this improves their experience following surgery
Condition Intervention
Total Knee Arthroplasty secondary to osteoarthritis
 Drug: Femoral perineural infusion

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Official Title: Improving Postoperative Rehabilitation Following Total Knee Arthroplasty with Perineural Local Anesthetic Infusion

Further Study Details: 
Primary Outcomes: (1) Distance of ambulation in the afternoon following surgery.; (2) Time from surgical stop until three discharge criteria are met
Expected Total Enrollment:  50

Study start: January 2005

What procedures would be done as part of your normal clinical care (even if you did not participate in this research)?

You will have some monitors placed (such as a blood-pressure cuff) and be given some medicines through your intravenous (IV) line to make you very sleepy. The anesthesiologist will then place a nerve block so that much of your knee (not all) will be numb. At the same time, the anesthesiologist will place a tiny tube, called a catheter, near your nerves that will be used after the surgery is over. You will still go to sleep for the surgery, but you will be much more comfortable when you wake up because the numbing medicine will be working to take away much of the pain. If you are not part of this study, you would go from the recovery room to a room in the hospital for 3-5 days, and your catheter would be removed the morning following surgery. After your catheter was removed, you would depend on oral and IV opioids—or pain medicine—to control your surgical pain. You would go home with only oral opioids since IV opioids cannot be provided at home.

What procedures will be done only because you are participating in this research study?

From the recovery room you will go to the Clinical Research Center (CRC) which is a special part of the hospital where research is undertaken. During your stay at the CRC you will have the ability to push a button on a small infusion pump to give yourself more medicine through the tube to your nerves if you have pain. If this does not help enough, you will take pain pills to help. And if this does not help enough, you will be given opioids (strong pain medicine like morphine) into your IV. Each morning after surgery, the medicine in your little infusion pump will be replaced by either (1) more medicine, or (2) salt water, or “normal saline”. The pharmacist will determine this randomly—like flipping a coin—and neither you nor the doctors/nurses caring for you will know which you have. This is to keep any of us from inadvertently/unconsciously affecting the results of the study. However, if you have pain that is not controlled with pain pills, you will be switched back to the regular medicine to improve your comfort until the following morning. You will undergo physical therapy and following this you will be checked to see if you are ready to go home. When you are ready to go home beginning on the third day after surgery, you may go home with the little infusion pump and the tube that goes to the nerves of your knee. One of the study physicians will call you each night to ensure that you are comfortable for the first 7 nights after your surgery, and you will be given the phone and pager numbers of a physician available for you to contact 24 hours/day, 7 days/week. When the medicine runs out or in the fourth evening following surgery, whichever comes first, your catheter will be removed. The pump is disposable, so it can be thrown away. A physician will call you the two nights after the catheter comes out to ensure that you are comfortable.

Eligibility

Ages Eligible for Study:  18 Years   -   80 Years,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Patients undergoing unilateral
  • Primary TKA
  • 18-80 years of age
  • Be able to understand the possible local anesthetic-related complications, study protocol, and care of the catheter and infusion pump system and are already planning on having a perineural catheter placed for postoperative analgesia

Exclusion Criteria:

  • Any contraindication to femoral block/catheter
  • Any comorbidity which results in moderate or severe functional limitation (ASA physical status >2)
  • Baseline oxygen saturation < 96% on room air
  • Known hepatic or renal insufficiency (creatinine level > 1.5 mg/dL)
  • Allergy to study medications (other than NSAIDs and acetaminophen)
  • Inability to communicate with the authors, morbid obesity (BMI>40 kg/m2)
  • History of opioid abuse or chronic regular opioid use use (use within the 2 weeks prior to surgery and duration of use > 4 weeks)

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00135889

Brian M Ilfeld, MD, MS      (352) 494-0316    bilfeld@ufl.edu

Florida
      University of Florida, Gainesville,  Florida,  32610-0254,  United States; Recruiting
Brian M Ilfeld, MD, MS  352-494-0316    bilfeld@ufl.edu 
Brian M Ilfeld, MD, MS,  Principal Investigator

Study chairs or principal investigators

Brian M Ilfeld, MD, MS,  Principal Investigator,  University of Florida   

More Information

Study ID Numbers:  560-2003; GCRC 582
Last Updated:  August 25, 2005
Record first received:  August 24, 2005
ClinicalTrials.gov Identifier:  NCT00135889
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-30

Resources




Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us